Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and 6-methyl-2-(phenylethynyl)pyridine

3,4-dihydroxyphenylacetic acid has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aloisi, G; Battaglia, G; Busceti, CL; Cerrito, F; De Blasi, A; Fornai, F; Melchiorri, D; Nicoletti, F1
Battaglia, G; Biagioni, F; Bruno, V; Busceti, CL; Fornai, F; Molinaro, G; Nicoletti, F; Storto, M1
Di Paolo, T; Grégoire, L; Morin, N; Morissette, M1

Other Studies

3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 6-methyl-2-(phenylethynyl)pyridine

ArticleYear
Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Mar-15, Volume: 22, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Excitatory Amino Acid Antagonists; Fever; Glial Fibrillary Acidic Protein; Homovanillic Acid; Hydroxybenzoates; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Inbred C57BL; Microdialysis; Nerve Tissue Proteins; Pyridines; Reactive Oxygen Species; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Tyrosine 3-Monooxygenase

2002
Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Jan-28, Volume: 24, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Homovanillic Acid; Mice; Mice, Knockout; MPTP Poisoning; Neuroprotective Agents; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Substantia Nigra; Survival Rate; Synaptosomes

2004
Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
    Progress in neuro-psychopharmacology & biological psychiatry, 2015, Jan-02, Volume: 56

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Brain; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Homovanillic Acid; Levodopa; Macaca fascicularis; Ovariectomy; Parkinsonian Disorders; Protein Binding; Pyridines; Serotonin

2015